More than 50% of people all over the world experienced a headache disorder in the past year, according to new research published in the Journal of Headache and Pain. The disorders—which include migraines, tension headaches, cluster headaches, and headaches related to things like exercise or sinusitis—affect 52% of people, the study found. Each day, an estimated 15.8% of the world’s population has a headaches, the researchers said.

FDA issued a draft guidance document for developing plans to enroll more participants in clinical trials from underrepresented racial and ethnic populations. The draft guidance advises sponsors of medical products to develop and submit a race and ethnicity diversity plan based on a framework outlined in the guidance to the agency early in clinical development.

The American Academy of Sleep Medicine has initiated an investigation into the safety of melatonin, which is increasingly used as a solution for chronic insomnia.

COVID-19 has intensified the mental health pandemic, said Julie A. Dopheide, PharmD, BCPP, FASHP. What’s worse is that access to mental health care continues to be a challenge for individuals.

A study in Open Forum Infectious Diseases revealed that among children aged 3 years or younger who were hospitalized for uncomplicated community-associated pneumonia (CAP), a sizable proportion of them fared well without undergoing a full course of antibiotics.